To read more on this topic click here.
Researchers present in-depth review of 145 clinical trials for Parkinson’s
News
Author: Sophie BatesPublished: 27 August 2020
Prep:
Cook:
Serves:
A recent report conducted by researchers at The Cure Parkinson’s Trust and research advocates, presents an in-depth review of current clinical trials that are targeting Parkinson’s.
With the global number of people living with Parkinson’s expected to double by 2040, the objective of the investigation was to increase awareness of clinical trials and create opportunities for collaboration between the research community and people with the condition.
As part of the review – published in the Journal of Parkinson’s Disease – researchers categorised 145 trials into the type of drug being tested and the stage of their clinical development, to highlight trends in how the condition is being targeted.
Parkinson’s research advocate Dr Kevin McFarthing, said: “The number of clinical trials under way is encouraging for the Parkinson’s community, especially the high proportion of repurposed initiatives that increase the chances of a new therapy becoming available quickly.”
For more information on the latest Parkinson’s research please visit the EPDA website.
Read more:
Can negative dreams predict long-term cognitive decline in Parkinson’s?
New machine learning model could help pinpoint stages of Parkinson’s
Last Month
Next Month
Share this story
Related articles
Europe
Copenhagen carnival: campaigners and cyclists join forces for Unity Walk
Copenhagen’s streets to be overrun with Parkinson’s campaigners
READ MORE
Global update
Campaigners living with Parkinson’s invited to apply for US$20,000 award
2015 Bakken Invitation Award open for entries
READ MORE
Resources & Tools
Brush up on your Parkinson’s terminology with this free glossary
Free downloadable and printable A-Z of Parkinson’s disease
READ MORE
Comments